OXT and autism spectrum disorder: Moreover, differential OXT agonism at AVPR1a could have important implications for understanding the therapeutic potential of nonapeptide treatments in alleviating symptoms associated with neurodevelopmental disorders such as autism spectrum disorders (ASD).